JP2003529555A5 - - Google Patents

Download PDF

Info

Publication number
JP2003529555A5
JP2003529555A5 JP2001549382A JP2001549382A JP2003529555A5 JP 2003529555 A5 JP2003529555 A5 JP 2003529555A5 JP 2001549382 A JP2001549382 A JP 2001549382A JP 2001549382 A JP2001549382 A JP 2001549382A JP 2003529555 A5 JP2003529555 A5 JP 2003529555A5
Authority
JP
Japan
Prior art keywords
reaction
item
equivalents
carried out
acetic anhydride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001549382A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003529555A (ja
Filing date
Publication date
Priority claimed from DE19963607A external-priority patent/DE19963607B4/de
Application filed filed Critical
Publication of JP2003529555A publication Critical patent/JP2003529555A/ja
Publication of JP2003529555A5 publication Critical patent/JP2003529555A5/ja
Pending legal-status Critical Current

Links

JP2001549382A 1999-12-23 2000-12-20 4−(ヘテロアリール−メチル)−ハロゲン−1(2h)−フタラジノンの製造方法 Pending JP2003529555A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19963607.9 1999-12-23
DE19963607A DE19963607B4 (de) 1999-12-23 1999-12-23 Verfahren zur Herstellung von 4-(Heteroaryl-methyl) halogen-1(2H)-phthalazinonen
PCT/EP2000/013027 WO2001047912A1 (de) 1999-12-23 2000-12-20 Verfahren zur herstellung von 4-(heteroaryl-methyl)-halogen-1(2h)-phthalazinonen

Publications (2)

Publication Number Publication Date
JP2003529555A JP2003529555A (ja) 2003-10-07
JP2003529555A5 true JP2003529555A5 (https=) 2008-02-14

Family

ID=7934888

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001549382A Pending JP2003529555A (ja) 1999-12-23 2000-12-20 4−(ヘテロアリール−メチル)−ハロゲン−1(2h)−フタラジノンの製造方法

Country Status (31)

Country Link
US (1) US6891041B2 (https=)
EP (1) EP1242405B1 (https=)
JP (1) JP2003529555A (https=)
KR (1) KR100654265B1 (https=)
CN (1) CN1221545C (https=)
AT (1) ATE273972T1 (https=)
AU (1) AU772981B2 (https=)
BG (1) BG65387B1 (https=)
BR (1) BR0016634A (https=)
CA (1) CA2395407C (https=)
CZ (1) CZ20022146A3 (https=)
DE (2) DE19963607B4 (https=)
DK (1) DK1242405T3 (https=)
EE (1) EE04940B1 (https=)
ES (1) ES2223626T3 (https=)
HR (1) HRP20020605B1 (https=)
HU (1) HUP0300992A3 (https=)
IL (2) IL150017A0 (https=)
MX (1) MXPA02006224A (https=)
NO (1) NO321357B1 (https=)
NZ (1) NZ519285A (https=)
PL (1) PL200714B1 (https=)
PT (1) PT1242405E (https=)
RO (1) RO121211B1 (https=)
RS (1) RS50458B (https=)
RU (1) RU2250900C2 (https=)
SI (1) SI1242405T1 (https=)
SK (1) SK285522B6 (https=)
UA (1) UA72021C2 (https=)
WO (1) WO2001047912A1 (https=)
ZA (1) ZA200205853B (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1296984B1 (it) * 1997-12-19 1999-08-03 Zambon Spa Derivati ftalazinici inibitori della fosfodiesterasi 4
US7151102B2 (en) * 2000-10-30 2006-12-19 Kudos Pharmaceuticals Limited Phthalazinone derivatives
GB0419072D0 (en) * 2004-08-26 2004-09-29 Kudos Pharm Ltd Phthalazinone derivatives
UY30639A1 (es) * 2006-10-17 2008-05-31 Kudos Pharm Ltd Derivados sustituidos de 2h-ftalazin-1-ona, sus formas cristalinas, proceso de preparacion y aplicaciones
CA2702429A1 (en) * 2007-10-17 2009-04-23 Kudos Pharmaceuticals Limited Crystalline form l 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2h-phthalazin-1-one
CA2737400C (en) * 2008-10-07 2016-11-22 Astrazeneca Uk Limited Pharmaceutical formulation 514
EP2968323A4 (en) 2013-03-13 2016-12-14 Flatley Discovery Lab PYRIDAZINONE COMPOUNDS AND METHODS FOR THE TREATMENT OF CYSTIC FIBROSIS
EP3271439B1 (en) * 2015-03-19 2018-11-07 Clariant International Ltd Biodegradable sugar-amide-surfactants for enhanced oil recovery

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE567431A (https=) * 1957-05-07
GB1293565A (en) * 1969-05-03 1972-10-18 Aspro Nicholas Ltd Aminophthalazines and pharmaceutical compositions thereof
IE47592B1 (en) * 1977-12-29 1984-05-02 Ici Ltd Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof,and process for their manufacture
EP0634404A1 (en) * 1993-07-13 1995-01-18 Rhone Poulenc Agriculture Ltd. Phtalazin derivatives and their use as pesticides
JP3919835B2 (ja) * 1994-08-09 2007-05-30 エーザイ・アール・アンド・ディー・マネジメント株式会社 縮合ピリダジン系化合物
DE69533057T2 (de) * 1994-08-09 2005-06-16 Eisai Co., Ltd. Kondensierte pyridazinverbindungen
RU2128175C1 (ru) * 1994-08-09 1999-03-27 Эйсай Ко., Лтд. Конденсированный пиридазин или его фармакологически приемлемая соль, средство, проявляющее ингибирующую активность в отношении циклической гмф- фосфодиэстеразы
ATE236134T1 (de) * 1996-12-18 2003-04-15 Neurogen Corp Isoquinolinamin und phtalazinamin derivate, die reagieren mit crf rezeptoren
CO4950519A1 (es) * 1997-02-13 2000-09-01 Novartis Ag Ftalazinas, preparaciones farmaceuticas que las comprenden y proceso para su preparacion
IT1296984B1 (it) * 1997-12-19 1999-08-03 Zambon Spa Derivati ftalazinici inibitori della fosfodiesterasi 4
ITMI981671A1 (it) * 1998-07-21 2000-01-21 Zambon Spa Derivati ftalazinici inibitori della fosfodisterasi 4
ITMI981670A1 (it) * 1998-07-21 2000-01-21 Zambon Spa Derivati ftalazinici inibitori della fosfodiesterasi 4
ITMI20000261A1 (it) * 2000-02-16 2001-08-16 Zambon Group Processo per la preparazione di piridiniliden-ftalidi

Similar Documents

Publication Publication Date Title
JP2001521739A5 (https=)
JP2002506648A5 (https=)
JP2004525194A5 (https=)
MXPA02008801A (es) Derivados de indol, proceso para la preparacion de los mismos y su uso.
JP2003520017A5 (https=)
JP2002533216A5 (https=)
NO20030341D0 (no) Skallmetallkatalysator og en forlöper for denne, en fremgangsmåte for fremstilling av disse og anvendelse av katalysatoren
JP2001515920A5 (https=)
AU2003206311A1 (en) Use of indole-3-acetic acids in the treatment of asthma, copd and other diseases
JP2002532112A5 (https=)
AU2002359161A1 (en) Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer's disease and conditions associated with glycogen synthase kinase-3
JP2002519182A5 (https=)
PL366401A1 (en) Novel vinyl carboxylic acid derivatives and their use as antidiabetics etc.
JP2007501782A5 (https=)
TWD106698S1 (zh) 個人混合杯
JP2003529555A5 (https=)
Daniel et al. Pharmacological techniques for the in vitro study of intestinal smooth muscles
JP2000141643A5 (https=)
JP2003524569A5 (https=)
JP2002509169A5 (https=)
PL1689410T3 (pl) Sposób zapobiegania i leczenia nadciśnieniowych chorób serca za pomocą selektywnych estrogenów: 8ß-winylo-estra-1,3,5(10)-trien-3,17ß-diolu i 17ß-fluoro-9a-winylo-estra-1,3,5(10)-trien-3,16a-diolu
Uchida et al. Summary of physicochemical properties of natural gas hydrate and associated gas-hydrate-bearing sediments, JAPEX/JNOC/GSC Mallik 2L-38 gas hydrate research well, by the Japanese research consortium
JP2000319390A5 (https=)
JPH10237071A5 (https=)
HUP0204187A3 (en) Process for the preparation of 1-oxo-1,3-dihydro-5-isobenzofurancarboxylic acid and its use for the production of citalopram